Danong Chen has been elected as the new president and CEO of Theranostics Health. Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company that was acquired by Genentech in 2007.
Prior to her tenure at Tanox she served as a manager in the health care practice section at Arthur D. Little. Chen also holds a PhD from Baylor College of Medicine as well as an MBA from Arthur D. Little School of Management in Boston.
Michael Goldberg plans to resign from his position on the board of directors of Genomic Health as of the next annual stockholders meeting in May, according to a company filing with the US Securities and Exchange Commission last week.